TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.
about
Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasisAnti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalHomeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer ProgressionCirculating cancer stem cells: the importance to selectFrom sprouting angiogenesis to erythrocytes generation by cancer stem cells: evolving concepts in tumor microcirculationMetastatic cancer stem cells: from the concept to therapeuticsBreast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticityProtein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerPy2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivoBidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneityCancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea AttentionTransforming growth factor β as regulator of cancer stemness and metastasisTGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loopsHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsA synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancerActivin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma.Cystine addiction of triple-negative breast cancer associated with EMT augmented death signalingHER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Cancer stem cells and tumor metastasis (Review).Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancerLong non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5pExcessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis.Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transitionEMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.Obesity and cancer--mechanisms underlying tumour progression and recurrencePeroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells.An integrated expression profiling reveals target genes of TGF-β and TNF-α possibly mediated by microRNAs in lung cancer cellsCrosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition.Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cellsEpithelial-mesenchymal transition in keratocystic odontogenic tumor: possible role in locally aggressive behavior.Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer CellsBTB-Zinc Finger Oncogenes Are Required for Ras and Notch-Driven Tumorigenesis in Drosophila.Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.Understanding cancer stem cell heterogeneity and plasticity.CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation.Epithelial cell culture models for the prevention and therapy of clinical breast cancer (Review).Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.
P2860
Q21245487-C3124E23-C228-4AA4-BD08-E97AEBC1D6DCQ26744536-9A5DF56A-7AFF-4CB8-A135-0A28F529E3F4Q26768428-308E9994-5E2F-4E95-85D6-00429B3316E1Q26778924-A6B1D7CC-CBDC-47C7-85A8-8221A1D4E2AEQ26827148-BAB2E346-23C9-42F1-9EFB-E805F0AF7A4BQ26850739-90551336-1038-4C27-9740-5F4EBCA52DDEQ26851620-9B522831-3800-4FE9-AF81-85E8A69018ECQ26852215-D4B4FA1F-F9B9-42F8-A28D-D0A7DF1798B0Q27340972-A1C3D8C3-62CF-434D-881D-AF69C7CE96AAQ28066409-0C78DAAA-C0EA-4709-AF6F-6CF49500762FQ28069232-B2ABC15F-D808-4235-80A8-208263B2CE75Q28077319-E86E80F5-4087-483A-B2DC-1413E0611286Q28248954-89F14CBE-B647-4DC3-8D8E-751D569951D9Q28393898-05A0DCB2-2C8E-45C3-BAF3-36D1FAA8FDC6Q28543036-EBC96DEE-3DFA-4062-B2C7-2D2D692A4D6DQ30301260-11E6CCE6-0C0F-4437-863D-4E413B5E0265Q30833237-2A6EDA39-16FA-42F6-981B-A76515B996AAQ33710602-86F94743-BFC7-4AB0-BB2E-EB04FBFF06CCQ33737278-8D7BB791-37E5-49AE-86D8-10BEE9CB6CCCQ33778124-7D328C67-533B-49DE-ACA4-06022CC74C8EQ33875120-72B5F3E4-8831-4750-9E44-716DBFCC956BQ33892569-515B3E20-68BF-47F9-84FA-16C27BF1DA4DQ34249060-D7D08F85-1386-4D54-B12D-0E27BF748913Q34271512-F500913B-7CA7-4C81-8A98-5C8FBBCBF0EFQ34288822-D653AF26-67AA-4C17-AF80-EAA92BA4F4DAQ34425077-EA552E00-6191-4053-BDBE-2CB31CC1A4A9Q34571496-ED75C53F-EF6F-41DD-8A37-D7793FAEB67DQ34599038-7FE1E512-F046-446E-99EE-C8BD0D2AF439Q34677454-37D93157-4330-4691-9000-FE2EB8FB1BF3Q35067924-E4EE5140-67B9-4B68-8BD2-90F55226479EQ35080755-233BF56A-4B00-4CF8-8BC3-159A5BF91C20Q35281849-574C83C6-3CFC-493B-BCEA-056AA4BBA01EQ35710589-B89E71B5-049D-48B7-BF44-6BB3FA97177EQ35711047-C4F72491-21FC-49A4-A592-54E679CAB6E4Q35762816-65D7684A-D585-43C2-8C1E-D83686A2ED8AQ35796886-68A5E0B7-E7EE-44BB-AC34-B0D5E11B52EBQ35941297-312AC92E-A94C-42AE-81E6-37980B0A030AQ35995983-2861191F-1B69-46DB-8A93-C3379A8614A1Q36015463-4E525CE7-79C0-425B-9055-ADBB7B3F4A88Q36040355-C915793F-74F9-4679-87FF-9442C0E6A77D
P2860
TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.
@ast
TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.
@en
type
label
TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.
@ast
TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.
@en
prefLabel
TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.
@ast
TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.
@en
P2093
P2860
P1433
P1476
TGFbeta/TNF(alpha)-mediated ep ...... with a claudin-low phenotype.
@en
P2093
Derek C Radisky
James N Ingle
Keith L Knutson
Marshall D Behrens
Michael K Asiedu
P2860
P304
P356
10.1158/0008-5472.CAN-10-4554
P407
P577
2011-05-09T00:00:00Z